| Accession |
PRJCA012888 |
| Title |
SHR-1210-III-307 SHR1210 plus carboplatin plus paclitaxel versus placebo plus carboplatin plus paclitaxel as first-line therapy for locally advanced or metastatic squamous non-small cell lung cancer |
| Relevance |
Medical |
| Data types |
clinical information,imaging,metabolic data,etc
|
| Organisms |
Homo sapiens
|
| Description |
Relevant data generated from the testing of clinical research samples. |
| Sample scope |
Multiisolate |
| Release date |
2022-10-31 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| NA
|
|
NA
|
|
|
|
| Submitter |
luchongyang
chongyang
lu (chongyang.lu@hengrui.com)
|
| Organization |
Jiangsu Hengrui Pharmaceutical Co. LTD |
| Submission date |
2022-10-31 |
